Department of Paediatric Endocrinology and Diabetes, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Department of Paediatric Endocrinology and Diabetes, St Georges Hospital, London, UK.
Pediatr Diabetes. 2017 Dec;18(8):835-838. doi: 10.1111/pedi.12486. Epub 2017 Jan 17.
Two Caucasian girls, both of normal weight and body mass indices, were diagnosed with type A insulin resistance (IR) in childhood. Case 1 presented with premature adrenarche aged 7 years, then by age 12 years had hirsutism, acne, acanthosis nigricans, and asymptomatic diabetes. Subsequent investigation revealed raised adiponectin (15.3 mg/L) and heterozygous p.Pro1205Leu mutation in the INSR gene encoding the insulin receptor. She experienced postprandial hypoglycaemia on metformin; acarbose was trialled and discontinued aged 16 years, as she became normoglycaemic. Hirsutism was treated with topical eflornithine, oral spironolactone and flutamide, and laser therapy. Unfortunately, diabetes reemerged in young adulthood with obesity. Case 2: during an emergency admission for acute abdominal pain aged 11 years, hyperglycaemia was noted which led to further investigation. An oral glucose tolerance test showed diabetes and ultrasound showed polycystic ovaries. Further investigations revealed raised adiponectin (18 mg/L) and compound heterozygous mutations in the INSR gene: p.Pro1263Ala and p.Ser748Leu (latter probable normal variant). She was treated with metformin and experienced postprandial hypoglycaemia. Symptoms of hyperandrogenism were controlled by flutamide. She maintained a healthy weight and reassessment at young adulthood showed resolution of diabetes. Type A IR may present in childhood with overlapping features of common endocrine entities such as premature adrenarche and polycystic ovarian syndrome. Patients with abnormal glucose tolerance yet normal weight merit screening with adiponectin; raised adiponectin levels prompt insulin receptor mutational analysis. Postprandial hypoglycaemia is characteristic. Management includes optimization of glycaemic control with oral hypoglycaemic agents and maintenance of healthy weight, and controlling the effects of hyperandrogenism.
两名白人女孩,体重和身体质量指数均正常,均在儿童时期被诊断为 A 型胰岛素抵抗(IR)。病例 1 在 7 岁时出现早熟性肾上腺功能亢进,12 岁时出现多毛症、痤疮、黑棘皮病和无症状性糖尿病。进一步的检查显示,其血清脂联素升高(15.3mg/L),编码胰岛素受体的 INSR 基因存在杂合 p.Pro1205Leu 突变。她在服用二甲双胍后出现餐后低血糖;16 岁时试用阿卡波糖,但因血糖恢复正常而停药。多毛症用局部依氟鸟氨酸、口服螺内酯和氟他胺治疗,并进行激光治疗。不幸的是,她在成年早期肥胖时再次出现糖尿病。病例 2:在 11 岁因急性腹痛紧急入院时,发现存在高血糖,进一步检查发现糖尿病,超声显示多囊卵巢。进一步检查发现血清脂联素升高(18mg/L),并存在 INSR 基因的复合杂合突变:p.Pro1263Ala 和 p.Ser748Leu(后者可能为正常变异)。她接受了二甲双胍治疗,出现餐后低血糖。通过氟他胺控制了高雄激素血症的症状。她保持健康的体重,成年早期的重新评估显示糖尿病已缓解。A 型 IR 可在儿童时期表现出与常见内分泌疾病(如早熟性肾上腺功能亢进和多囊卵巢综合征)重叠的特征。存在异常葡萄糖耐量但体重正常的患者需要通过检测脂联素进行筛查;脂联素水平升高提示胰岛素受体基因突变分析。餐后低血糖是其特征性表现。治疗包括通过口服降糖药物优化血糖控制,维持健康体重,以及控制高雄激素血症的影响。